Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prostate cancer
Richard J. Rebello, Christoph Oing, Karen E. Knudsen, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Closed Access | Times Cited: 734

Showing 1-25 of 734 citing articles:

Prostate cancer
Shahneen Sandhu, Caroline M. Moore, Edmund Chiong, et al.
The Lancet (2021) Vol. 398, Iss. 10305, pp. 1075-1090
Open Access | Times Cited: 396
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
Qing Wu, Wei Qian, Xiaoli Sun, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 135
Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer
Thanakorn Pungsrinont, Julia Kallenbach, Aria Baniahmad
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11088-11088
Open Access | Times Cited: 127
Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer
Cameron Herberts, Matti Annala, Joonatan Sipola, et al.
Nature (2022) Vol. 608, Iss. 7921, pp. 199-208
Closed Access | Times Cited: 117
The pyroptotic role of Caspase-3/GSDME signalling pathway among various cancer: A Review
Asif Ahmad Bhat, Riya Thapa, Obaid Afzal, et al.
International Journal of Biological Macromolecules (2023) Vol. 242, pp. 124832-124832
Closed Access | Times Cited: 100
Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review
Ruo-Gu Xiong, Siyu Huang, Si-Xia Wu, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4523-4523
Open Access | Times Cited: 87
Complexities of Prostate Cancer
Sobia Wasim, Sang‐Yoon Lee, Jaehong Kim
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14257-14257
Open Access | Times Cited: 86
Liquid Biopsy in Prostate Cancer Management—Current Challenges and Future Perspectives
Felice Crocetto, Gianluca Russo, Erika Di Zazzo, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3272-3272
Open Access | Times Cited: 77
Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer
Hanling Wang, Ni Li, Qiuli Liu, et al.
Cancer Cell (2023) Vol. 41, Iss. 7, pp. 1345-1362.e9
Closed Access | Times Cited: 74
Alternative splicing and related RNA binding proteins in human health and disease
Yining Tao, Qi Zhang, Haoyu Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 72
Radiotheranostics in oncology: Making precision medicine possible
Eric O. Aboagye, Tara Barwick, Uwe Haberkorn
CA A Cancer Journal for Clinicians (2023) Vol. 73, Iss. 3, pp. 255-274
Open Access | Times Cited: 69
The function and mechanisms of action of circular RNAs in Urologic Cancer
Zi-Hao Zhang, Yue Wang, Ya Zhang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 53
Global Burden of Prostate Cancer and Association with Socioeconomic Status, 1990–2019: A Systematic Analysis from the Global Burden of Disease Study
Weiyu Zhang, Guiying Cao, Feng Wu, et al.
Journal of Epidemiology and Global Health (2023) Vol. 13, Iss. 3, pp. 407-421
Open Access | Times Cited: 48
A Comprehensive Review and Androgen Deprivation Therapy and Its Impact on Alzheimer’s Disease Risk in Older Men with Prostate Cancer
Manisha Singh, Vinayak Agarwal, Pranav Pancham, et al.
Degenerative Neurological and Neuromuscular Disease (2024) Vol. Volume 14, pp. 33-46
Open Access | Times Cited: 30
Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells
Manuel Colucci, Sara Zumerle, Silvia Bressan, et al.
Cancer Cell (2024) Vol. 42, Iss. 4, pp. 646-661.e9
Open Access | Times Cited: 27
A developmental constraint model of cancer cell states and tumor heterogeneity
Ayushi Patel, Itai Yanai
Cell (2024) Vol. 187, Iss. 12, pp. 2907-2918
Closed Access | Times Cited: 27
In Situ‐Sprayed Bioinspired Adhesive Conductive Hydrogels for Cavernous Nerve Repair
Shuting Wang, Zhenqing Wang, Wei Yang, et al.
Advanced Materials (2024) Vol. 36, Iss. 19
Closed Access | Times Cited: 19
Lanthanide MOF-based luminescent sensor arrays for the detection of castration-resistant prostate cancer curing drugs and biomarkers
Xinrui Wang, Karuppasamy Gopalsamy, Gilles Clavier, et al.
Chemical Science (2024) Vol. 15, Iss. 17, pp. 6488-6499
Open Access | Times Cited: 19
Clinical advances of mRNA vaccines for cancer immunotherapy
Alexey V. Yaremenko, Muhammad Muzamil Khan, Xueyan Zhen, et al.
Med (2025) Vol. 6, Iss. 1, pp. 100562-100562
Closed Access | Times Cited: 4
Identification, structure, and agonist design of an androgen membrane receptor
Zhao Yang, Yu-Qi Ping, Ming‐Wei Wang, et al.
Cell (2025)
Closed Access | Times Cited: 3
Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challenges
Mintu Pal, Thingreila Muinao, Hari Prasanna Deka Boruah, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112488-112488
Open Access | Times Cited: 70
ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression
Ni Li, Qiuli Liu, Ying Han, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 57
Advances and development of prostate cancer, treatment, and strategies: A systemic review
Sana Belkahla, Insha Nahvi, Supratim Biswas, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 47
Unamplified and Real‐Time Label‐Free miRNA‐21 Detection Using Solution‐Gated Graphene Transistors in Prostate Cancer Diagnosis
Minghua Deng, Zhanpeng Ren, Huibin Zhang, et al.
Advanced Science (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 45
Current and emerging therapies for neuroendocrine prostate cancer
Busola R. Alabi, Shiqin Liu, Tanya Stoyanova
Pharmacology & Therapeutics (2022) Vol. 238, pp. 108255-108255
Closed Access | Times Cited: 41
Page 1 - Next Page

Scroll to top